• No results found

Cover Page The handle

N/A
N/A
Protected

Academic year: 2021

Share "Cover Page The handle"

Copied!
6
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Cover Page

The handle http://hdl.handle.net/1887/81820 holds various files of this Leiden University dissertation.

Author: Koedoot, E.

(2)
(3)

ISBN

978-94-028-1744-7

Printing: Ipskamp Printing, Amsterdam

Printing of this thesis was kindly supported by Nikon

© 2019 Esmee Koedoot

All rights reserved. No part of this thesis may be reproduced, stored, translated or transmitted in any form or by any means now or hereafter, electronic or mechanical, without written permission from the author.

RNA splicing in breast cancer progression

(4)

RNA splicing

in breast cancer progression

Proefschrift

ter verkrijging van

de graad van Doctor aan de Universiteit Leiden

op gezag van de Rector Magnificus, prof. mr. C.J.J.M. Stolker,

volgens besluit van het College voor Promoties

te verdedigen op dinsdag 17 december 2019 klokke 15 uur

door

Esmee Koedoot

(5)

Promotor

Prof. Dr. B. van de Water Drug Discovery and Safety, LACDR, Leiden University, Leiden

Co-promotor

Dr. S.E. Le Dévédec Drug Discovery and Safety, LACDR, Leiden University, Leiden

Promotion committee

Prof. Dr. H. Irth Biomolecular Analysis, LACDR, Leiden University, Leiden, president

Prof. Dr. J.A. Bouwstra BioTherapeutics, LACDR. Leiden University, Leiden, secretary

Prof. Dr. J.W.M. Martens Medical Oncology, Erasmus MC, Rotterdam

Prof. Dr. A. Sonnenberg Cell Biology, Netherlands Cancer Institute, Amsterdam Prof. Dr. P. ten Dijke Cell and Chemical Biology, LUMC, Leiden

Prof. Dr. B.E. Snaar-Jagalska Cell Biology and Genetics, IBL, Leiden University, Leiden

(6)

Table of Contents

Chapter 1 1

Introduction, aim and scope of the thesis

Chapter 2 9

Uncovering the signaling landscape controlling breast cancer cell migration identifies novel metastasis driver genes

Chapter 3 37

Splicing factors and hallmarks of breast cancer

Chapter 4 55

Co-regulated gene expression of splicing factors as drivers of cancer progression

Chapter 5 75

Unraveling the spliceosomal control of breast cancer cell motility behavior

Chapter 6 97

Splicing factors control triple-negative breast cancer cell mitosis through SUN2 interaction and sororin intron retention

Chapter 7 121

Differential reprogramming of breast cancer subtypes in 3D cultures and implications for sensitivity to targeted therapy

Chapter 8 139

Discussion and Conclusion

Appendix 149

References 150

Abbreviations 167

Nederlandse Samenvatting 169

List of Publications 173

Referenties

GERELATEERDE DOCUMENTEN

The research described in this thesis was performed at the Division of BioTherapeutics, Leiden Academic Center for Drug Research, Leiden University, Leiden, The Netherlands.

This research was conducted at the Division of Drug Discovery and Safety of the Leiden Academic Centre for Drug Research, Leiden University, Leiden, The

The research described in this thesis was performed at the division of Drug Discovery and Safety of the Leiden Academic Centre for Drug Research (LACDR), Leiden University, The

Rob Vreeken at the department of Analytical Biosciences under the Leiden Academic Centre for Drug Research (LACDR), at Leiden University in Leiden, the Netherlands...

The research described in this thesis was performed at the Division of Drug Delivery Technology of the Leiden Academic Centre for Drug Research (LACDR) and at the Leiden

The research described in this thesis was performed at the Leiden University Medical Center, the Leiden Academic Center for Drug Research and the Centre for Human Drug Research and

The research described in this thesis was performed at the division Drug Discovery and Safety of Leiden Academic Centre for Drug Research (LACDR), Leiden.. University (Leiden,

The research described in this thesis was performed at the division of Biotherapeu- tics of the Leiden Academic Centre for Drug Research (LACDR), Leiden University (Leiden,